ADARx Pharmaceuticals (ADRX) vs uniQure N.V. (QURE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
ADARx Pharmaceuticals is the larger company by market cap ($1.42 billion vs $1.36 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADRX | QURE |
|---|---|---|
| Share price | $12.79 | $19.35 |
| Market cap | $1.42B | $1.36B |
| 1-day change | -9.68% | -4.35% |
| YTD return | — | -19.14% |
| 1-year return | — | -30.42% |
| 5-year return | — | -32.86% |
| EPS (TTM) | $-6.75 | $-3.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $16.10M |
| Revenue growth (YoY) | — | -40.64% |
| Net income (latest FY) | — | $-198.97M |
| Gross margin | — | 89.53% |
| Operating margin | — | -1151.38% |
| Net margin | — | -1236.00% |
| 52-week high | $23.21 | $51.72 |
| 52-week low | $12.50 | $8.73 |
| Distance from 52-week high | -44.89% | -62.59% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +167.79% | +207.03% |
| Average volume | 650.63K | 2.26M |
| Shares outstanding | 111.19M | 70.14M |
| Employees | 100 | 221 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ADARx Pharmaceuticals
ADRX stock →ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About uniQure N.V.
QURE stock →uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 221 employees
ADRX vs QURE FAQ
Which is bigger, ADARx Pharmaceuticals or uniQure N.V.?
ADARx Pharmaceuticals (ADRX) is larger, with a market capitalization of $1.42B compared with $1.36B for uniQure N.V. (QURE).
Are ADARx Pharmaceuticals and uniQure N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.